Study	1
the Ef ciency	10
Transplantation of Human Neural Stem Cells to Rats with Spinal Trauma	28
Transplantation	28
Human Neural Stem Cells to Rats with Spinal Trauma	47
Human Neural Stem Cells	47
Rats with Spinal Trauma	74
Rats	74
Spinal Trauma	84
the Use of Functional Load Tests	99
the Use	99
Functional Load Tests	110
BBB Test S. V. Lebedev	136
A. V. Karasev	161
V. P. Chekhonin	176
E. A. Savchenko	193
I. V. Viktorov	210
Yu	226
A.	230
Chelyshev *	233
Chelyshev	233
, and G. F. Shaimardanova	243
G.	249
Translated from Byulleten '	271
Translated	271
Byulleten '	287
Eksperimental '	298
noi Biologii	312
noi	312
Biologii	316
i	325
Meditsiny , Vol	327
Meditsiny	327
Vol	338
149	343
No. 3	348
No.	348
3	352
pp. 355-360	355
pp.	355
355-360	359
March	368
2010	375
Original article	381
April 29 , 2009	408
Human ensheating neural stem cells of the olfactory epithelium	426
Human ensheating neural stem cells	426
the olfactory epithelium	464
adult male rats	510
contusion trauma	544
the spinal cord at T9 level rostrally and caudally to the injury	564
the spinal cord	564
T9 level	583
the injury	618
Voluntary movements -LRB- by a 21-point BBB scale -RRB-	630
Voluntary movements	630
a 21-point BBB scale	654
rota-rod performance	677
a narrowing beam	717
60 days	761
rats	773
cell transplantation	788
the mean BBB score	810
11 %	856
the end of the experiment	863
the end	863
the experiment	874
The mean parameters of load tests	890
The mean parameters	890
load tests	913
the corresponding parameters	949
controls	981
The efficiency of transplantation	991
The efficiency	991
transplantation	1009
percent of animals with motor function recovery parameters	1026
percent	1026
animals with motor function recovery parameters	1037
animals	1037
motor function recovery parameters	1050
the corresponding mean values	1096
the control groups	1129
62 %	1153
the state of voluntary motions	1160
the state	1160
voluntary motions	1173
37 % by the rota-rod test	1192
37 %	1192
the rota-rod test	1199
32 % by the narrowing beam test	1222
32 %	1222
the narrowing beam test	1229
Morphometry	1254
considerable shrinking	1275
the zone	1301
traumatic damage	1313
the spinal cord and activation of posttraumatic remyelination	1333
the spinal cord and activation	1333
posttraumatic remyelination	1367
animals receiving transplantation of human neural stem cells	1398
animals	1398
transplantation of human neural stem cells	1416
transplantation	1416
human neural stem cells	1435
Fundamental studies	1461
the tissue	1484
cellular levels in the field of experimental cell therapy of spinal traumas	1499
cellular levels	1499
the field of experimental cell therapy of spinal traumas	1518
the field	1518
experimental cell therapy of spinal traumas	1531
experimental cell therapy	1531
spinal traumas	1560
the existence	1585
a considerable reparative potential	1602
transplanted preparations of stem -LRB- progenitor -RRB- cells	1641
transplanted preparations	1641
stem -LRB- progenitor -RRB- cells	1670
stem -LRB- progenitor -RRB-	1670
stem	1670
progenitor	1676
cells	1688
functional recovery of motor functions -LRB- organism level -RRB-	1699
functional recovery	1699
motor functions -LRB- organism level -RRB-	1722
motor functions	1722
organism level	1739
minimum -LSB- 5,6,11 -RSB-	1759
This discrepancy	1777
methodical problems	1814
particular	1838
subjectivity	1852
the method	1868
semiquantitative evaluation	1882
voluntary motions -LRB- BBB test -RRB- used in practically all studies	1913
voluntary motions	1913
BBB test	1932
practically all studies	1950
the error of the method according to authors ' estimation	1975
the error	1975
the method according to authors ' estimation	1988
the method	1988
authors ' estimation	2012
authors '	2012
1-2 points	2044
the 21-point scale -LSB- 4 -RSB-	2059
the 21-point scale	2059
4 -RSB-	2079
various reports	2096
the maximum improvement	2113
the motor functions	2140
this scale	2163
transplantation	2180
cell preparations	2199
animals with contusion traumas of the spinal cord -LRB- CTSC -RRB-	2220
animals	2220
contusion traumas of the spinal cord -LRB- CTSC -RRB-	2233
contusion traumas	2233
the spinal cord -LRB- CTSC -RRB-	2254
the spinal cord	2254
CTSC	2271
2-3 points	2292
the control -LSB- 3,5-7,9-11,13 -RSB-	2315
the control	2315
3,5-7,9-11,13 -RSB-	2328
The problem	2344
functional load tests	2379
objective evaluation of motor function recovery , physical working capacity	2410
objective evaluation	2410
motor function recovery , physical working capacity	2434
motor function recovery	2434
physical working capacity	2459
adaptive capacities of the whole orga nism	2490
adaptive capacities	2490
the whole orga nism	2513
2 -RSB-	2534
we	2543
this methodological approach	2553
preclinical evaluation	2586
the efficiency	2612
transplanta tion of neural stem cells -LRB- NSC -RRB- of human olfactory mucosa	2630
transplanta tion	2630
neural stem cells -LRB- NSC -RRB- of human olfactory mucosa	2650
neural stem cells -LRB- NSC -RRB-	2650
neural stem cells	2650
NSC	2669
human olfactory mucosa	2677
rats in acute period of CTSC	2703
rats	2703
acute period of CTSC	2711
acute period	2711
CTSC	2727
MATERIALS AND METHODS	2734
Experiments	2756
53	2788
albino male rats	2799
300-350 g	2825
standard conditions of experimental biological clinics	2852
standard conditions	2852
experimental biological clinics	2875
free access	2912
food and water	2927
The olfactory epithelium tissue	2943
Neurovita hospital	2991
patients	3015
spinal traumas	3029
the procedure	3045
Ethical committee of Russian State Medical University	3075
Ethical committee	3075
Russian State Medical University	3096
Fragments of the olfactory mucosa -LRB- 10 × 5 mm -RRB-	3131
Fragments	3131
the olfactory mucosa -LRB- 10 × 5 mm -RRB-	3144
the olfactory mucosa	3144
10 × 5 mm	3166
10 × 5	3166
10	3166
5	3169
mm	3171
the upper portion of the superior turbinate	3193
the upper portion	3193
the superior turbinate	3214
local lidocaine anesthesia	3243
The tissue sample	3271
the laboratory in cold Ca2	3308
the laboratory	3308
cold Ca2	3326
+	3334
Mg2	3336
+	3339
free Hanks saline	3341
antibiotics and antimycotics -LRB- 1:100 , Gibco -RRB- not later than 2 h	3370
antibiotics and antimycotics -LRB- 1:100 , Gibco -RRB-	3370
antibiotics and antimycotics	3370
1:100	3400
Gibco	3407
2 h	3429
isolation	3439
The samples	3450
the same buffer	3490
blood vessels	3507
the tissue	3539
trypsin and EDTA -LRB- 0.25 % -RRB-	3580
trypsin and EDTA	3580
0.25 %	3598
0.01 M phosphate buffered saline -LRB- pH 7.4 -RRB- at 36.5 oC for 40 min	3608
0.01 M phosphate	3608
saline -LRB- pH 7.4 -RRB-	3634
saline	3634
pH 7.4	3642
36.5 oC for 40 min	3653
36.5 oC	3653
40 min	3664
The enzymes	3672
DMEM -LRB- Gibco -RRB- containing 3 % serum	3702
Gibco	3708
3 % serum	3726
the tissue	3736
3 times	3758
balanced Hanks saline	3771
repeated pipetting in a nutrient medium	3812
repeated pipetting	3812
a nutrient medium	3834
Nutrient media	3853
the following composition	3872
DMEM/F12 -LRB- Gibco -RRB-	3899
DMEM/F12	3899
Gibco	3909
10 % FCS -LRB- Gibco -RRB-	3917
10 % FCS	3917
Gibco	3926
2 mM glutamine -LRB- Gibco -RRB-	3934
2 mM glutamine	3934
Gibco	3950
0.8 % glucose , insulin + transferrin	3958
0.8 %	3958
glucose , insulin + transferrin	3963
sodium selenute -LRB- Gibco , 1:100 -RRB- , 20 mM HEPES	3992
sodium selenute	3992
Gibco	4009
1:100	4016
20 mM HEPES	4024
growth factors -LRB- only for primary cultures -RRB-	4041
growth factors	4041
primary cultures	4066
fibroblast growth factor -LRB- 1 ng/ml ; Sigma -RRB- and nerve growth factor	4085
fibroblast growth factor -LRB- 1 ng/ml ; Sigma -RRB-	4085
fibroblast growth factor	4085
1 ng/ml ; Sigma	4111
1 ng/ml	4111
Sigma	4120
nerve growth factor	4131
2 ng/ml ; Sigma	4152
2 ng/ml	4152
Sigma	4161
The cell suspension	4169
1200 rpm for 7 min	4208
1200 rpm	4208
7 min	4221
the pellet	4231
the same medium	4261
Only cell suspensions containing 90-95 % viable cells	4278
Only cell suspensions	4278
90-95 % viable cells	4311
90-95 %	4311
further culturing	4345
cells	4376
12-well plates	4399
polylysine-coated substrate for 14 h	4417
polylysine-coated substrate	4417
14 h	4449
The medium	4455
twice a week	4484
The primary culture after attaining a confluent state	4498
The primary culture	4498
a confluent state	4534
trypsin-EDTA -LRB- 0.25 % -RRB-	4571
trypsin-EDTA	4571
0.25 %	4585
Hanks balanced saline solution -LRB- HBSS -RRB-	4603
Hanks balanced saline solution	4603
HBSS	4635
nutrient medium	4674
The cell suspension	4691
25	4730
cm flasks	4734
the substrate neurospheres	4777
enzyme treatment	4838
Suspension of neurosphere cells	4856
Suspension	4856
neurosphere cells	4870
glial cells	4928
fibroblasts	4941
stromal -LRB- supportive -RRB- cells attached to the substrate	4958
stromal -LRB- supportive -RRB- cells	4958
the substrate	4997
The cultures	5012
4 times	5047
A portion of cells of the last passages	5056
A portion	5056
cells of the last passages	5069
cells	5069
the last passages	5078
liquid nitrogen	5121
The composition of NSC preparation	5138
The composition	5138
NSC preparation	5157
immunocytochemical analysis of passage 3 neurospheres	5190
immunocytochemical analysis	5190
passage 3 neurospheres	5221
subsequent 2-week culturing after defrosting	5248
subsequent 2-week culturing	5248
defrosting	5282
Cells of neurospheres	5294
Cells	5294
neurospheres	5303
nestin -LRB- neuronfilament protein -RRB- and B-tubulin	5336
nestin	5336
neuronfilament protein	5344
B-tubulin	5372
3-fold washout of NSC in cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5388
3-fold washout	5388
NSC in cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5406
NSC	5406
cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5413
cold -LRB- 4 °C -RRB- Hanks saline	5413
4 °C	5419
cell viability	5438
trypan blue exclusion test	5470
trypan	5470
blue exclusion test	5477
this parameter	5498
> 95 %	5517
>	5517
a suspension	5527
cells concentration of 100,000 cells per 1 ml Hanks saline was prepared	5545
cells concentration	5545
100,000 cells per 1 ml Hanks saline was prepared	5568
100,000 cells	5568
1 ml Hanks saline was prepared	5586
1 ml	5586
Hanks saline	5591
Sterile preparation of NSC	5618
Sterile preparation	5618
NSC	5641
5 min	5665
the operation room	5685
the time to transplantation	5705
the time	5705
transplantation	5717
1.5 h	5748
this period	5762
the preparation	5774
4 °C	5804
CTSC	5809
8 -RSB-	5850
The rats	5854
5 % ketamine -LRB- 120 mg/kg -RRB- and 0.5 % seduxen -LRB- 5 mg/kg -RRB-	5902
5 % ketamine -LRB- 120 mg/kg -RRB-	5902
5 % ketamine	5902
120 mg/kg	5915
0.5 % seduxen -LRB- 5 mg/kg -RRB-	5930
0.5 % seduxen	5930
5 mg/kg	5944
laminectomy at Th9 level	5960
laminectomy	5960
Th9 level	5975
the spine	5986
metal clips	6019
the spinous processes of vertebrae Th8 and Th10	6034
the spinous processes	6034
vertebrae Th8 and Th10	6059
vertebrae Th8	6059
Th10	6077
contusion of the spinal cord	6089
contusion	6089
the spinal cord	6102
a metal rod	6135
2 mm in diameter , 10 mg	6148
2 mm	6148
diameter , 10 mg	6156
diameter	6156
10 mg	6166
a stereotaxis micromanipulator	6182
a height of 12.5 mm	6241
a height	6241
12.5 mm	6253
The epicenter of the damage	6262
The epicenter	6262
the damage	6279
the central line of the spinal cord	6305
the central line	6305
the spinal cord	6325
the boundary with Th8	6344
the boundary	6344
Th8	6362
Th8 laminectomy	6373
NSC	6409
two points at the bondaries	6436
two points	6436
the bondaries	6450
Th7 and Th10	6469
the cranial injection	6483
0.3 mm	6514
the left and the caudal one 0.3 mm	6524
the left	6524
the caudal one 0.3 mm	6537
the right from the central line	6562
the right	6562
the central line	6577
damage	6603
the central channel of the spinal cord	6613
the central channel	6613
the spinal cord	6636
We	6653
750,000 cells in 10 µl Hanks medium in each point , i.e. 1.5 mln cells per rat	6665
750,000 cells	6665
10 µl	6682
Hanks medium in each point	6688
Hanks medium	6688
each point	6704
1.5 mln cells per rat	6721
1.5 mln cells	6721
rat	6739
experimental group	6744
30 rats	6776
Controls -LRB- 23 rats -RRB-	6786
Controls	6786
23 rats	6796
Hanks solution	6814
the same conditions	6835
Hamilton syringe	6856
a steel needle -LRB- G29 -RRB- connected to a micropump	6878
a steel needle	6878
G29	6894
a micropump	6912
o.	6936
The cells	6950
a depth of 1.2 mm	6977
a depth	6977
1.2 mm	6988
the rate of needle introduction	6996
the rate	6996
needle introduction	7008
10 µ/sec	7032
the rate of injection	7042
the rate	7042
injection	7054
1 µl/min	7068
The needle	7078
5 min	7103
the end of transplantation	7115
the end	7115
transplantation	7126
The operation wound	7143
layer-by-layer	7175
Antibiotics	7191
postoperation days 1-3	7233
postoperation days	7233
1-3	7252
voiding	7257
the abdominal wall	7288
the urinary bladder	7313
The rats	7334
the same time of the day for 2 consecutive days	7365
the same time	7365
the day for 2 consecutive days	7382
the day	7382
2 consecutive days	7394
day	7417
1 voluntary movements by the BBB test	7421
1 voluntary movements	7421
the BBB test	7446
coordination disturbances by the narrowing beam test	7463
coordination disturbances	7463
the narrowing beam test	7492
day	7537
2 rota-rod performance	7541
2 -RSB-	7579
Morphological studies	7583
a biomaterial taken 7 , 30 , and 60 days after trauma	7625
a biomaterial	7625
7 , 30 , and 60 days	7645
7	7645
30	7648
60 days	7656
trauma	7670
The animals	7678
200 mg/kg ketamine intraperitoneally	7707
200 mg/kg	7707
ketamine intraperitoneally	7717
ketamine	7717
perfused transcardially with cold -LRB- 4oC -RRB- 4 % paraformaldehyde	7746
4oC	7781
phosphate buffer -LRB- pH 7.4 -RRB-	7809
phosphate buffer	7809
pH 7.4	7827
a fragment	7840
spinal cord	7854
the vertebrae	7871
5 cm fragment length , 2.5 cm caudally and caudally from the lesion epicenter	7886
5 cm fragment length	7886
2.5 cm caudally and caudally from the lesion epicenter	7908
2.5 cm	7908
caudally and caudally from the lesion epicenter	7915
the lesion	7942
12 h	7981
the fragment	7987
5 portions -LRB- 1 cm each -RRB-	8017
5 portions	8017
1 cm each	8029
1 cm	8029
each	8034
the caudal one	8075
Fragments 1 , 3 , and 5	8091
2.5 % glutaraldehyde and 1 % OsO4	8131
2.5 % glutaraldehyde	8131
1 % OsO4	8155
epon 812	8191
Fragments 2 and 4	8201
Fragments	8201
2 and 4	8211
10 % neutral formalin , dehydrated , and embedded in paraffin	8233
10 % neutral formalin	8233
paraffin	8283
The area of pathological cavities	8293
The area	8293
pathological cavities	8305
the amount of myelinated fibers at distances of 3 and 5 mm rostrally	8331
the amount	8331
myelinated fibers at distances of 3 and 5 mm rostrally	8345
myelinated fibers	8345
distances of 3 and 5 mm rostrally	8366
distances	8366
3 and 5 mm rostrally	8379
3 and 5 mm	8379
the epicenter of lesion	8413
the epicenter	8413
lesion	8430
semithin sections	8455
the spinal cord prepared on an LKB III microtome and stained with methylene blue	8476
the spinal cord	8476
an LKB III microtome	8504
methylene blue	8542
The area	8558
the white and gray matter	8570
distances of 1 and 1.5 cm from the epicenter of the lesion	8599
distances	8599
1 and 1.5 cm from the epicenter of the lesion	8612
1 and 1.5 cm	8612
the epicenter of the lesion	8630
the epicenter	8630
the lesion	8647
paraffin sections	8674
Morphometrical parameters	8693
4 zones of the white matter	8737
4 zones	8737
the white matter	8748
ventromedial part	8769
the anterior funiculus adjacent to the medial fissure on the right side	8790
the anterior funiculus	8790
the medial fissure on the right side	8825
the medial fissure	8825
the right side	8847
2 -RRB- the same on the left side	8863
the same	8866
the left side	8878
3 -RRB- lateral part of the lateral funiculus within the frontal plane	8893
lateral part	8896
the lateral funiculus within the frontal plane	8912
the lateral funiculus	8912
the frontal plane	8941
the central channel , right side ; 4 -RRB- the same on the left side	8975
the central channel	8975
right side ; 4 -RRB- the same on the left side	8996
right side	8996
4 -RRB- the same on the left side	9008
the same	9011
the left side	9023
fluorescent visualization of the transplanted cells	9042
fluorescent visualization	9042
the transplanted cells	9071
500,000 NSC stained with CFDA-SE -LRB- Invitrogen -RRB- in 5 µl Hanks medium	9095
500,000 NSC	9095
CFDA-SE -LRB- Invitrogen -RRB- in 5 µl Hanks medium	9120
CFDA-SE -LRB- Invitrogen -RRB-	9120
CFDA-SE	9120
Invitrogen	9129
5 µl Hanks	9144
5 experimental rats	9183
2 above described points	9208
2	9208
described points	9216
The cells	9234
transplantation	9276
this end	9296
NSC	9306
1 mM CFDA-SE in DMSO -LRB- 1:100 -RRB-	9328
1 mM CFDA-SE	9328
DMSO -LRB- 1:100 -RRB-	9344
DMSO	9344
1:100	9350
phosphate	9360
saline for 15 min	9379
saline	9379
15 min	9390
37 °C and then	9400
37 °C	9400
then	9409
DMEM for 30 min at 37oC	9417
DMEM	9417
30 min at 37oC	9426
30 min	9426
37oC	9436
The fragment of the spinal cord	9442
The fragment	9442
the spinal cord	9458
day 7	9487
cryostat sections	9518
The data	9537
Student 's t , Wilcoxon -- White , Mann-Whitney , x2 and Fisher exact tests	9581
Student 's t , Wilcoxon	9581
Student 's t	9581
Student 's	9581
Wilcoxon	9594
White , Mann-Whitney , x2 and Fisher exact tests	9603
White	9603
Mann-Whitney	9610
x2	9624
Fisher exact tests	9631
RESULTS	9652
1	9666
Efficiency of NSC	9669
Efficiency	9669
NSC	9683
the Acute Period of CTSC in Rats -LRB- 60 Days after Trauma -RRB- Fig. 1	9706
the Acute Period	9706
CTSC	9726
Rats -LRB- 60 Days after Trauma -RRB-	9734
Rats	9734
60 Days after Trauma	9740
60 Days	9740
Trauma	9754
Fig. 1	9763
Dynamics	9771
functional tests	9783
transplantation	9806
NSC	9825
human olfactory mucosa	9834
rats	9860
the acute period	9868
CTSC	9888
a -RRB- voluntary movements by the BBB scale	9894
a -RRB- voluntary movements	9894
the BBB scale	9920
rota-rod	9938
holding -LRB- 21 rpm -RRB-	9947
holding	9947
21 rpm	9956
; c -RRB- distance of error-free walking on the narrowing beam	9963
; c -RRB- distance of error-free	9963
distance	9968
error-free	9980
the narrowing beam	10002
CTSC+H	10025
anks saline	10031
anks	10031
-LRB- control -RRB- ; 2 -RRB- CTSC+NSC transplantation	10043
-LRB- control -RRB-	10043
2 -RRB- CTSC+NSC transplantation	10054
p	10084
< 0.05 compared to the control .	10085
<	10085
0.05	10086
the control	10103
Fig. 2 .	10117
Fig.	10117
2	10122
Effect	10125
NSC transplantation	10135
nervous tissue recovery in rats with CTSC 30 days	10158
nervous tissue recovery	10158
rats with CTSC 30 days	10185
rats	10185
CTSC	10195
30 days	10200
surgery and transplantation	10214
a , b -RRB-	10243
a	10243
total area of cavities	10249
total area	10249
cavities	10263
c , d -RRB- amount	10273
myelinated fibers ; a , c -RRB- 3 mm caudally	10289
myelinated fibers	10289
a	10308
c	10311
3 mm	10314
the lesion epicenter	10331
b , d	10353
b	10353
d	10356
5 mm	10359
bars : experiment ; dark bars : control	10370
bars	10370
experiment ; dark bars	10376
experiment	10376
dark bars	10388
control	10399
p	10409
< 0.05 compared to the control .	10410
<	10410
0.05	10411
the control	10428
Animal mortality	10442
the control and experimental groups	10486
the control	10486
experimental groups	10502
26 and 23 % , respectively	10523
26 and 23 %	10523
26	10523
23 %	10530
Transplantation of NSC	10550
Transplantation	10550
NSC	10569
little effect on body weight gain	10577
little effect	10577
body weight gain	10594
body weight by the end of the experiment	10612
body weight	10612
the end of the experiment	10627
the end	10627
the experiment	10638
448 ± 12 g	10657
448	10657
12 g	10661
the control group and 449 ± 15 g	10669
the control group	10669
449 ± 15 g	10691
449	10691
15 g	10695
the experimental group	10703
BBB testing	10727
gradual partial spontaneous recovery of voluntary movements	10748
gradual partial spontaneous recovery	10748
voluntary movements	10788
rats of the control group	10811
rats	10811
the control group	10819
BBB score	10838
7.8 ± 0.2 one	10863
week	10875
surgery	10886
12.5 ± 0.3	10897
the end of the experiment -LRB- Fig. 1 , a -RRB-	10909
the end	10909
the experiment -LRB- Fig. 1 , a -RRB-	10920
the experiment	10920
Fig. 1 , a	10936
Fig. 1	10936
a	10944
rats	10951
NSC transplantation	10966
the recovery of voluntary movements	10987
the recovery	10987
voluntary movements	11003
the second week of monitoring	11057
the second week	11057
monitoring	11076
The mean increase in BBB score in the experimental group	11088
The mean increase	11088
BBB score in the experimental group	11109
BBB score	11109
the experimental group	11122
4.5 ± 0.4 vs. 2.5 ± 0.3 in the control -LRB- p ≤ 0.02 -RRB- after 30 days	11149
± 0.4	11152
2.5 ± 0.3 in the control -LRB- p ≤ 0.02 -RRB-	11161
2.5 ±	11161
0.3	11165
the control -LRB- p ≤ 0.02 -RRB-	11172
the control	11172
p ≤ 0.02	11185
p	11185
≤ 0.02	11186
30	11199
5.8 ± 0.3	11211
5.8 ±	11211
0.3	11215
4.5 ± 0.3 -LRB- p ≤ 0.002 -RRB-	11223
4.5 ±	11223
0.3 -LRB- p ≤ 0.002 -RRB-	11227
0.3	11227
p ≤ 0.002	11232
p	11232
≤ 0.002	11233
60 days	11247
The positive effect of NSC transplantation on recovery of voluntary movements	11256
The positive effect	11256
NSC transplantation on recovery of voluntary movements	11279
NSC transplantation	11279
recovery of voluntary movements	11302
recovery	11302
voluntary movements	11314
the analysis	11356
relative parameters	11372
The percent of animals with BBB	11392
The percent	11392
animals with BBB	11407
animals	11407
BBB	11420
13	11431
the control	11437
experimental groups	11453
30 days	11479
0 and 50 % -LRB- p ≤ 0.05 -RRB-	11491
0	11491
50 % -LRB- p ≤ 0.05 -RRB-	11497
50 %	11497
p ≤ 0.05	11502
p	11502
≤ 0.05	11503
60 days	11531
the corresponding values	11539
25 and 84 % -LRB- p ≤ 0.05 -RRB-	11569
25 and 84 %	11569
p ≤ 0.05	11581
p	11581
≤ 0.05	11582
the experimental group	11593
the percent	11617
animals	11632
maximum increase in this parameter -LRB- > 5 -RRB- 60 days after CTSC	11645
maximum increase	11645
this parameter -LRB- > 5 -RRB- 60 days after CTSC	11665
this parameter -LRB- > 5 -RRB-	11665
this parameter	11665
> 5	11681
60 days	11685
CTSC	11699
the control : 100 and 38 % , respectively	11741
the control	11741
100 and 38 %	11754
100	11754
38 %	11762
p	11781
≤ 0.05	11782
Transplantation of NSC	11790
Transplantation	11790
NSC	11809
the time of hol ding	11823
the time	11823
hol ding	11835
the rotating rod	11847
the rota-rod apparatus	11867
the corresponding parameter	11902
the control group throughout the monitoring period	11933
the control group	11933
the monitoring period	11962
these changes	11989
Fig. 1	12037
b	12045
The tendency to improvement of locomotor function after trans plantation of NSC	12049
The tendency	12049
improvement of locomotor function after trans plantation of NSC	12065
improvement	12065
locomotor function after trans plantation of NSC	12080
locomotor function	12080
trans plantation of NSC	12105
trans plantation	12105
NSC	12125
appreciable increase	12146
the percent	12170
rats	12185
the rotating rod -LRB- 21 rpm -RRB- from 63 % in the control group	12212
the rotating rod -LRB- 21 rpm -RRB-	12212
the rotating rod	12212
21 rpm	12230
63 % in the control group	12243
63 %	12243
the control group	12250
100 % in the experimental group	12271
100 %	12271
the experimental group	12279
the end of the experiment	12305
the end	12305
the experiment	12316
Transplantation of NSC	12332
Transplantation	12332
NSC	12351
the mean distance	12370
error-free walking along the narrowing beam -LRB- Fig. 1 , c -RRB-	12391
error-free walking	12391
the narrowing beam -LRB- Fig. 1 , c -RRB-	12416
the narrowing beam	12416
Fig. 1	12436
c	12444
Signi cant differences from the control in this parameter	12448
Signi cant differences	12448
the control in this parameter	12477
the control	12477
this parameter	12492
the first 2 weeks of testing	12533
the first 2 weeks	12533
testing	12554
This	12563
intraparenchymatous transplantation of NSC in the acute period of CTSC	12582
intraparenchymatous transplantation	12582
NSC in the acute period of CTSC	12621
NSC	12621
the acute period of CTSC	12628
the acute period	12628
CTSC	12648
a short-term neuroprotective effect	12662
Analysis	12699
the relative number	12711
animals walking more than 50 cm along the narrowing beam without errors	12734
animals	12734
more than 50 cm along the narrowing beam	12750
more than 50 cm	12750
the narrowing beam	12772
errors	12799
positive effect of NSC transplantation	12822
positive effect	12822
NSC transplantation	12841
hind limb coordination	12864
the experimental group	12891
the percent	12915
animals	12930
50 cm along the narrowing beam	12947
50 cm	12947
the narrowing beam	12959
errors after 30 and 60 days	12986
errors	12986
30 and 60 days	12999
the corresponding parameter	13024
the control group	13055
5 and 2 times	13076
Calculation	13105
NSC transplantation efficiency	13120
comparison	13156
the number	13170
rats	13184
considerable recovery	13194
impaired functions -LRB- above the mean values in the control group -RRB-	13219
impaired functions	13219
the mean values in the control group	13245
the mean values	13245
the control group	13264
the end of the experiment	13286
the end	13286
the experiment	13297
considerable therapeutic effect	13321
the parameters of voluntary movements -LRB- BBB scale -RRB-	13356
the parameters	13356
voluntary movements -LRB- BBB scale -RRB-	13374
voluntary movements	13374
BBB scale	13395
improvement	13413
tests -LRB- rota-rod and narrowing beam -RRB-	13445
tests	13445
rota-rod and narrowing beam	13452
rota-rod	13452
narrowing beam	13465
Table 1	13514
Morphological analysis of CTSC zone	13524
Morphological analysis	13524
CTSC zone	13550
the character	13572
the volume of damage to the gray and white matter in experimental rats	13590
the volume	13590
damage to the gray and white matter in experimental rats	13604
damage	13604
the gray and white matter in experimental rats	13614
the gray and white matter	13614
experimental rats	13643
medium-severity CTSC -LRB- weight fall from a height of 12.5 mm -RRB-	13677
medium-severity CTSC	13677
weight fall from a height of 12.5 mm	13699
weight fall	13699
a height of 12.5 mm	13716
a height	13716
12.5 mm	13728
4 -RSB-	13738
CFDA-SE-labeled NSC transplanted into the spinal cord	13742
CFDA-SE-labeled NSC	13742
the spinal cord	13780
at least 7 days	13812
Their migration along the periphery of the lesion focus in the spinal cord	13829
Their migration	13829
the periphery of the lesion focus in the spinal cord	13851
the periphery	13851
the lesion focus in the spinal cord	13868
the lesion focus	13868
the spinal cord	13888
Transplantation of NSC 5 mm rostrally and caudally to the lesion epicenter	13918
Transplantation	13918
NSC 5 mm	13937
the lesion epicenter	13972
the formation of pathological cavities	14017
the formation	14017
pathological cavities	14034
the anterior funiculus of the white matter -LRB- Fig. 2 , b -RRB-	14059
the anterior funiculus	14059
the white matter -LRB- Fig. 2 , b -RRB-	14085
the white matter	14085
Fig. 2	14103
b	14111
This phenomenon	14115
sites	14154
the epicenter of the lesion -LRB- Fig. 2 , a -RRB-	14172
the epicenter	14172
the lesion -LRB- Fig. 2 , a -RRB-	14189
the lesion	14189
Fig. 2 , a	14201
Fig. 2	14201
a	14209
the neuroprotective effect of NSC transplantation	14241
the neuroprotective effect	14241
NSC transplantation	14271
the periphery of lesion site in the spinal cord tissue	14294
the periphery	14294
lesion site in the spinal cord tissue	14311
lesion site	14311
the spinal cord tissue	14326
NSC transplantation	14350
a positive effect on the process of posttraumatic remyelination	14379
a positive effect	14379
the process of posttraumatic remyelination	14400
the process	14400
posttraumatic remyelination	14415
The amount	14444
myelin fibers	14458
the lesion area -LRB- 3 mm from the epicenter -RRB- in the experimental group	14475
the lesion area -LRB- 3 mm from the epicenter -RRB-	14475
the lesion area	14475
3 mm from the epicenter	14492
3 mm	14492
the epicenter	14502
the experimental group	14520
the corresponding parameter	14553
controls -LRB- Fig. 2 , c -RRB-	14584
controls	14584
Fig. 2	14594
c	14602
the same time	14609
this effect	14624
the analysis of spinal cord sections	14656
the analysis	14656
spinal cord sections	14672
greater distance	14696
the epicenter -LRB- 5 mm , Fig. 2 , d -RRB-	14718
the epicenter	14718
5 mm	14733
Fig. 2	14739
d	14747
additional trauma	14777
this level caused by injection of the cell preparation at this site	14798
this level	14798
injection of the cell preparation	14819
injection	14819
the cell preparation	14832
this site	14856
the area of the white and gray matter at a distance of 1 and 1.5 cm	14880
the area	14880
the white and gray matter at a distance of 1 and 1.5 cm	14892
the white and gray matter	14892
a distance of 1 and 1.5 cm	14921
a distance	14921
1 and 1.5 cm	14935
the epicenter of the trauma	14953
the epicenter	14953
the trauma	14970
no significant differences between the control and experimental groups	14990
no significant differences	14990
the control and experimental groups	15025
the control	15025
experimental groups	15041
Low	15062
absolute -LRB- mean -RRB- values	15066
mean	15076
locomotion recovery parameters in our experiments	15092
locomotion recovery parameters	15092
our experiments	15126
the results of previous experiments	15153
the results	15153
previous experiments	15168
cell therapy of spinal cord injuries -LSB- 3,7,10,11,13,15 -RSB-	15192
cell therapy	15192
spinal cord injuries -LSB- 3,7,10,11,13,15 -RSB-	15208
spinal cord injuries	15208
3,7,10,11,13,15 -RSB-	15230
Insufficient level of functional reparation	15248
Insufficient level	15248
functional reparation	15270
peculiar tissue damage in spinal cord injuries	15312
peculiar tissue damage	15312
spinal cord injuries	15338
disruption	15360
long nerve conduction pathways -LRB- corticospinal and rubrospinal tracts -RRB-	15374
long nerve conduction pathways	15374
corticospinal and rubrospinal tracts	15406
corticospinal	15406
rubrospinal tracts	15424
the absence of physiological -LRB- phylogenetic -RRB- mechanisms	15448
the absence	15448
physiological -LRB- phylogenetic -RRB- mechanisms	15463
their continuity	15517
12,14 -RSB-	15535
the efficiency of cell therapy of CTSC	15559
the efficiency	15559
cell therapy of CTSC	15577
cell therapy	15577
CTSC	15593
we	15598
the means of functional recovery parameters	15617
the means	15617
functional recovery parameters	15630
the percent of animals with recovery parameters	15666
the percent	15666
animals with recovery parameters	15681
animals	15681
recovery parameters	15694
the mean level in the control group	15720
the mean level	15720
the control group	15738
the end of the experiment -LRB- 60 days after surgery -RRB-	15759
the end	15759
the experiment -LRB- 60 days after surgery -RRB-	15770
the experiment	15770
60 days after surgery	15786
60 days	15786
surgery	15800
The efficiency	15810
NSC transplantation into the spncal cord during the acute stage of CTSC	15828
NSC transplantation	15828
the spncal cord during the acute stage of CTSC	15853
the spncal cord	15853
the acute stage of CTSC	15876
the acute stage	15876
CTSC	15895
62 %	15904
the BBB test -LRB- recovery of voluntary movements -RRB-	15911
the BBB test	15911
recovery of voluntary movements	15925
recovery	15925
voluntary movements	15937
32 and 37 % by load tests narrowing beam and rota-rod	15962
32 and 37 %	15962
load tests narrowing beam and rota-rod	15976
load tests	15976
beam and rota-rod	15997
These results	16030
an argument	16048
clinical testing of NSC preparation	16073
clinical testing	16073
NSC preparation	16093
CTSC	16112
the same time	16124
the question	16142
the necessity of search	16158
the necessity	16158
search	16175
new methods	16186
modulation	16201
phylogenetic sanogenetic mechanisms	16215
recovery of integral functions in spinal cord injuries	16263
recovery	16263
integral functions in spinal cord injuries	16275
integral functions	16275
spinal cord injuries	16297
The study	16319
the Russian Foundation	16346
Basic Research -LRB- grant 08-04-01167 and 07 - 04-00746 -RRB-	16373
Basic Research	16373
grant 08-04-01167 and 07 - 04-00746	16389
grant 08-04-01167	16389
07 - 04-00746	16411
